150 related articles for article (PubMed ID: 37061778)
1. Acute Immune Reconstitution Inflammatory Syndrome-HBV Flare in an HIV/HBV Coinfected Patient After Antiretroviral Therapy Initiation: Case Report and Literature Review.
Arshad I; Gandhi M; Gossai M; Feinstein A
Am J Case Rep; 2023 Apr; 24():e939210. PubMed ID: 37061778
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
[TBL] [Abstract][Full Text] [Related]
3. [A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].
Mitsumoto F; Murata M; Ikezaki H; Ogawa E; Taniai H; Toyoda K; Otaguro S; Kainuma M; Okada K; Furusyo N; Hayashi J
Kansenshogaku Zasshi; 2012 Nov; 86(6):763-7. PubMed ID: 23367852
[TBL] [Abstract][Full Text] [Related]
4. Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients.
Yoshikawa S; Yoshio S; Yoshida Y; Tsutsui Y; Kawai H; Yamazoe T; Mori T; Osawa Y; Sugiyama M; Iwamoto M; Watashi K; Kawaguchi T; Akita T; Tanaka J; Kikuchi Y; Mizokami M; Oka S; Kanto T; Gatanaga H
J Infect Dis; 2021 Jun; 223(12):2080-2089. PubMed ID: 33073291
[TBL] [Abstract][Full Text] [Related]
5. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B-Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen-Positive Patient With HIV: Viroimmunological and Histological Characterization.
Iannetta M; Crea AMA; Di Lorenzo A; Campogiani L; Teti E; Malagnino V; Compagno M; Coppola L; Piermatteo L; Palmieri G; Cimino C; Salpini R; Zingaropoli MA; Ciardi MR; Mastroianni CM; Parisi SG; Svicher V; Andreoni M; Sarmati L
Open Forum Infect Dis; 2022 Sep; 9(9):ofac451. PubMed ID: 36092833
[TBL] [Abstract][Full Text] [Related]
7. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
[TBL] [Abstract][Full Text] [Related]
8. Increased human immunodeficiency virus viral load with cerebral infarction due to varicella zoster virus vasculopathy on treatment with bictegravir/emtricitabine/tenofovir alafenamide suspension: a case report and literature review.
Ishikawa K; Kawai F; Mori N
AIDS Res Ther; 2023 Jul; 20(1):53. PubMed ID: 37518182
[TBL] [Abstract][Full Text] [Related]
9. Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
Matthews GV; Ali RJ; Avihingsanon A; Amin J; Hammond R; Bowden S; Lewin SR; Sasadeusz J; Littlejohn M; Locarnini SL; Ruxrungtham K; Dore GJ
PLoS One; 2013; 8(4):e61297. PubMed ID: 23593455
[TBL] [Abstract][Full Text] [Related]
10. Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion.
Rowley MW; Patel A; Zhou W; Wong M; Seetharam AB
Ann Hepatol; 2019; 18(1):220-224. PubMed ID: 31113594
[TBL] [Abstract][Full Text] [Related]
11. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
12. Case report: An occult hepatitis B virus infection reactivation in an HIV/HCV coinfected patient during an immune reconstitution inflammatory syndrome.
Zaltron S; Cambianica A; Di Gregorio M; Colangelo C; Storti S; Tiecco G; Castelli F; Quiros-Roldan E
Front Cell Infect Microbiol; 2023; 13():1143346. PubMed ID: 37124041
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study.
Sarowar A; Coffin CS; Fung S; Wong A; Doucette K; Truong D; Conway B; Haylock-Jacobs S; Ramji A; Hansen BE; Janssen HLA; Cooper C
J Acquir Immune Defic Syndr; 2022 Dec; 91(4):368-372. PubMed ID: 36288543
[TBL] [Abstract][Full Text] [Related]
14. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
[TBL] [Abstract][Full Text] [Related]
15. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus.
Huang YS; Sun HY; Chang SY; Chuang YC; Su YC; Liu WC; Hung CC
Int J Antimicrob Agents; 2022; 60(5-6):106682. PubMed ID: 36279976
[TBL] [Abstract][Full Text] [Related]
16. Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection.
van Bremen K; Hoffmann C; Mauss S; Lutz T; Ingiliz P; Spinner CD; Scholten S; Schwarze-Zander C; Berger F; Breitschwerdt S; Schneeweiss S; Busch F; Wasmuth JC; Fätkenheuer G; Lehmann C; Rockstroh JK; Boesecke C
Liver Int; 2020 Dec; 40(12):2978-2981. PubMed ID: 33012099
[TBL] [Abstract][Full Text] [Related]
17. Increased viral load in a hospitalized patient on treatment with crushed bictegravir/emtricitabine/tenofovir alafenamide: A case report and review of the literature.
Rowe SM; Clary JC; Drummond M; Derrick C; Sanasi K; Bookstaver PB
Am J Health Syst Pharm; 2022 Aug; 79(16):1330-1336. PubMed ID: 35511892
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy.
Mitsumoto F; Murata M; Kato Y; Ura K; Takayama K; Hiramine S; Ikezaki H; Shimizu M; Toyoda K; Ogawa E; Aishima S; Furusyo N; Hayashi J
Intern Med; 2014; 53(18):2165-70. PubMed ID: 25224208
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.
Tajima K; Kohno K; Shiono Y; Suzuki I; Kato Y; Hiroshima Y; Yamamoto M; Ohtake H; Iwaba A; Yamakawa M; Kato T
Int J Clin Exp Pathol; 2013; 6(3):536-42. PubMed ID: 23411777
[TBL] [Abstract][Full Text] [Related]
20. Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study.
Dezanet LNC; Miailhes P; Lascoux-Combe C; Chas J; Maylin S; Gabassi A; Rougier H; Delaugerre C; Lacombe K; Boyd A
J Antimicrob Chemother; 2021 Oct; 76(11):3009-3019. PubMed ID: 34458919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
